Literature DB >> 22634882

HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up.

Mariana Tomazini Pinto1, Evandra Strazza Rodrigues, Tathiane Maistro Malta, Rochele Azevedo, Osvaldo Massaiti Takayanagui, Vanderléia Bárbaro Valente, Eugênia Maria Amorim Ubiali, Dimas Tadeu Covas, Simone Kashima.   

Abstract

The seroprevalence and geographic distribution of HTLV-1/2 among blood donors are extremely important to transfusion services. We evaluated the seroprevalence of HTLV-1/2 infection among first-time blood donor candidates in Ribeirão Preto city and region. From January 2000 to December 2010, 1,038,489 blood donations were obtained and 301,470 were first-time blood donations. All samples were screened with serological tests for HTLV-1/2 using enzyme immunoassay (EIA). In addition, the frequency of coinfection with hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), Chagas disease (CD) and syphilis was also determined. In-house PCR was used as confirmatory test for HTLV-1/2. A total of 296 (0.1%) first-time donors were serologically reactive for HTLV-1/2. Confirmatory PCR of 63 samples showed that 28 were HTLV-1 positive, 13 HTLV-2 positive, 19 negative and three indeterminate. Regarding HTLV coinfection rates, the most prevalent was with HBV (51.3%) and HCV (35.9%), but coinfection with HIV, CD and syphilis was also detected. The real number of HTLV-infected individual and coinfection rate in the population is underestimated and epidemiological studies like ours are very informative.

Entities:  

Mesh:

Year:  2012        PMID: 22634882     DOI: 10.1590/s0036-46652012000300002

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  16 in total

1.  Rapid and Sensitive Qualitative Duoplex Real-Time PCR Method for Discriminatory and Confirmatory Diagnosis of HTLV-1 and HTLV-2 Infections: Brazilian Multicentric Study.

Authors:  Mauricio Cristiano Rocha-Junior; Evandra Strazza Rodrigues; Svetoslav Nanev Slavov; Tatiane Assone; Maíra Pedreschi; Debora Glenda Lima de La Roque; Maisa Sousa; Viviana Olavarria; Bernardo Galvão-Castro; Benedito Antonio Lopes da Fonseca; Augusto César Penalva de Oliveira; Jerusa Smid; Oswaldo Massaiti Takayanagui; Jorge Casseb; Dimas Tadeu Covas; Simone Kashima
Journal:  Front Med (Lausanne)       Date:  2022-06-09

Review 2.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

3.  Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.

Authors:  Mariana Tomazini Pinto; Tathiane Maistro Malta; Evandra Strazza Rodrigues; Daniel Guariz Pinheiro; Rodrigo Alexandre Panepucci; Kelen Cristina Ribeiro Malmegrim de Farias; Alessandra De Paula Sousa; Osvaldo Massaiti Takayanagui; Yuetsu Tanaka; Dimas Tadeu Covas; Simone Kashima
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-16       Impact factor: 2.205

4.  In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.

Authors:  Ria Mulherkar; Aykan Karabudak; Rashida Ginwala; Xiaofang Huang; Aileen Rowan; Ramila Philip; Edward L Murphy; Danielle Clements; Lishomwa C Ndhlovu; Zafar K Khan; Pooja Jain
Journal:  Vaccine       Date:  2018-07-10       Impact factor: 3.641

5.  High prevalence of HTLV-1 infection among Japanese immigrants in non-endemic area of Brazil.

Authors:  Larissa M Bandeira; Silvia N O Uehara; Marcel A Asato; Gabriela S Aguena; Cristiane M Maedo; Nikolas H Benites; Marco A M Puga; Grazielli R Rezende; Carolina M Finotti; Gabriela A Cesar; Tayana S O Tanaka; Vivianne O L Castro; Koko Otsuki; Ana C P Vicente; Carlos E Fernandes; Ana R C Motta-Castro
Journal:  PLoS Negl Trop Dis       Date:  2015-04-17

Review 6.  HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status.

Authors:  Elisabetta Pilotti; Maria V Bianchi; Andrea De Maria; Federica Bozzano; Maria G Romanelli; Umberto Bertazzoni; Claudio Casoli
Journal:  Front Microbiol       Date:  2013-12-23       Impact factor: 5.640

7.  Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil.

Authors:  João Américo Domingos; Luana Silva Soares; Larissa M Bandeira; Camila Mareti Bonin; Ana C P Vicente; Louise Zanella; Marco Antonio Moreira Puga; Inês Aparecida Tozetti; Ana Rita Coimbra Motta-Castro; Rivaldo Venâncio da Cunha
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

8.  Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran.

Authors:  Gharib Karimi; Maryam Zadsar; Ali Akbar Pourfathollah
Journal:  Virol J       Date:  2017-01-30       Impact factor: 4.099

9.  HIV-1, HBV, HCV, HTLV, HPV-16/18, and Treponema pallidum infections in a sample of Brazilian men who have sex with men.

Authors:  Caroline C Soares; Ingebourg Georg; Elisabeth Lampe; Lia Lewis; Mariza G Morgado; Alcina F Nicol; Adriana A Pinho; Regina C S Salles; Sylvia L M Teixeira; Ana Carolina P Vicente; Raphael P Viscidi; Selma A Gomes
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

Review 10.  Epidemiology and treatment of psoriasis: a Brazilian perspective.

Authors:  Gleison V Duarte; Larissa Porto-Silva; Maria de Fátima Paim de Oliveira
Journal:  Psoriasis (Auckl)       Date:  2015-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.